tiprankstipranks
Trending News
More News >
Vertex Pharmaceuticals (DE:VX1)
XETRA:VX1

Compare Vertex Pharmaceuticals (VX1) vs. Competitors

Compare
23 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Vertex Pharmaceuticals
€389.95
€99.66B
30.54
0.57%
16 Buy
6 Hold
0 Sell
Moderate Buy
Alnylam Pharma
$400.59
$52.92B
1,666.35
69.73%
17 Buy
4 Hold
0 Sell
Strong Buy
Incyte
$100.11
$19.65B
16.79
46.32%
9 Buy
8 Hold
1 Sell
Moderate Buy
Regeneron
$784.97
$82.50B
18.79
11.71%
16 Buy
6 Hold
1 Sell
Moderate Buy
Argenx Se
$844.92
$52.14B
39.69
36.29%
17 Buy
3 Hold
0 Sell
Strong Buy
BioNTech SE
$94.52
$22.73B
-15.44%
12 Buy
3 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:VX1
Vertex Pharmaceuticals
389.85
2.20
0.57%
ALNY
Alnylam Pharma
400.59
164.58
69.73%
INCY
Incyte
100.11
31.69
46.32%
REGN
Regeneron
780.50
81.79
11.71%
ARGX
Argenx Se
844.92
224.96
36.29%
BNTX
BioNTech SE
95.20
-17.38
-15.44%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts